US Stock MarketDetailed Quotes
TIL Instil Bio
- 84.5200
- +38.0600+81.92%
Close Sep 13 16:00 ET
- 88.9900
- +4.4700+5.29%
Post 20:01 ET
549.71MMarket Cap-4595P/E (TTM)
92.0000High48.2700Low3.92MVolume50.0000Open46.4600Pre Close265.32MTurnover130.19%Turnover RatioLossP/E (Static)6.50MShares92.000052wk High2.82P/B254.71MFloat Cap6.060052wk Low--Dividend TTM3.01MShs Float589.8000Historical High--Div YieldTTM94.12%Amplitude6.0600Historical Low67.6270Avg Price1Lot Size
Instil Bio Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 45.75%-10.61M | 58.48%-14.39M | 54.47%-82.03M | 63.81%-13.38M | 64.71%-14.43M | 58.61%-19.56M | 37.04%-34.66M | -47.51%-180.16M | 13.59%-36.98M | -39.06%-40.88M |
| Net income from continuing operations | 20.07%-14.92M | 57.42%-24.3M | 30.06%-156.09M | 76.00%-12.93M | -19.93%-67.43M | 68.37%-18.66M | -5.45%-57.07M | -42.34%-223.18M | 2.72%-53.84M | -30.74%-56.22M |
| Operating gains losses | 307.44%641K | 1,609.76%701K | 3,769.57%844K | 105.63%125K | 90.54%987K | -114.48%-309K | 109.03%41K | -103.24%-23K | -2,156.48%-2.22M | -7.00%518K |
| Depreciation and amortization | -1.61%975K | -44.09%993K | -20.56%4.76M | -50.64%1.04M | -50.85%953K | -5.62%991K | 97.55%1.78M | 117.55%5.99M | 135.05%2.1M | 153.80%1.94M |
| Other non cash items | 8.33%1.7M | 18.45%-840K | -445.48%-8.5M | -256.86%-9.84M | -21.44%788K | 348.50%1.57M | -224.55%-1.03M | -345.13%-1.56M | -657.89%-2.76M | 460.34%1M |
| Change In working capital | 80.99%-1.02M | 147.72%1.82M | 5.75%-9.02M | 81.26%-1.05M | -73.67%1.23M | -602.90%-5.38M | 60.68%-3.81M | -319.35%-9.57M | -359.56%-5.61M | 38.47%4.67M |
| -Change in prepaid assets | 260.03%1.17M | 273.22%1.34M | 43.95%-241K | -51.61%841K | -82.83%419K | 59.17%-728K | 72.64%-773K | 91.48%-430K | 180.17%1.74M | 2,564.65%2.44M |
| -Change in payables and accrued expense | 69.79%-1.05M | 132.98%878K | 17.44%-8.9M | 73.85%-2.95M | -93.63%190K | -195.08%-3.48M | 56.55%-2.66M | -167.78%-10.78M | -247.24%-11.3M | -41.53%2.98M |
| -Change in other current assets | 35.06%-704K | -394.03%-197K | 335.88%1.54M | -47.82%1.27M | 307.72%1.29M | 6.79%-1.08M | 123.02%67K | 105.44%354K | 172.71%2.43M | 61.82%-622K |
| -Change in other current liabilities | -366.67%-434K | 55.16%-200K | -209.51%-1.42M | -113.57%-206K | -420.16%-671K | -125.83%-93K | 2.19%-446K | --1.29M | --1.52M | ---129K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 45.75%-10.61M | 58.48%-14.39M | 54.47%-82.03M | 63.81%-13.38M | 64.71%-14.43M | 58.61%-19.56M | 37.04%-34.66M | -47.51%-180.16M | 13.59%-36.98M | -39.06%-40.88M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 15.35%11.92M | -36.38%9.24M | -64.09%41.13M | -57.47%13.95M | -90.86%2.32M | 148.05%10.33M | -81.34%14.53M | 124.14%114.54M | -45.29%32.8M | 104.91%25.37M |
| Net PPE purchase and sale | --0 | --0 | 75.57%-20.66M | 99.55%-58K | 79.53%-5.16M | 73.30%-6.98M | 58.16%-8.47M | -46.27%-84.59M | 29.53%-13.01M | -15.88%-25.2M |
| Net investment purchase and sale | -34.28%11.38M | -59.80%9.24M | -69.75%60.23M | -72.82%12.45M | -85.22%7.48M | 272.92%17.31M | -76.56%23M | 147.80%199.13M | -41.58%45.81M | 110.22%50.57M |
| Net other investing changes | ---- | ---- | --1.56M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 15.35%11.92M | -36.38%9.24M | -64.09%41.13M | -57.47%13.95M | -90.86%2.32M | 148.05%10.33M | -81.34%14.53M | 124.14%114.54M | -45.29%32.8M | 104.91%25.37M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -88.76%8.08M | 0 | -103.99%-587K | -91.70%4.2M | 1,221.60%4.47M | -81.72%71.89M | 3,032.32%6.2M | 12,066.94%14.72M |
| Net issuance payments of debt | --0 | --0 | -88.51%8.08M | --0 | -104.06%-587K | -91.61%4.2M | --4.47M | --70.34M | --5.83M | --14.45M |
| Proceeds from stock option exercised by employees | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -11.90%1.55M | 89.90%376K | 122.31%269K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | -88.76%8.08M | --0 | -103.99%-587K | -91.70%4.2M | 1,221.60%4.47M | -81.72%71.89M | 3,032.32%6.2M | 12,066.94%14.72M |
| Net cash flow | ||||||||||
| Beginning cash position | -80.43%5.48M | -75.53%10.7M | 14.77%43.72M | -75.62%10.15M | -46.64%22.93M | -54.78%28.03M | 14.77%43.72M | -84.24%38.09M | 99.13%41.62M | -92.42%42.96M |
| Current changes in cash | 125.96%1.31M | 67.13%-5.15M | -624.01%-32.82M | -71.94%569K | -1,523.27%-12.69M | 72.28%-5.03M | -167.66%-15.67M | 103.08%6.26M | -88.32%2.03M | 99.86%-782K |
| Effect of exchange rate changes | 89.04%-8K | -162.50%-63K | 68.45%-201K | -127.14%-19K | 84.90%-85K | 91.64%-73K | -103.29%-24K | -109.54%-637K | 139.77%70K | -529.77%-563K |
| End cash Position | -70.42%6.78M | -80.43%5.48M | -75.53%10.7M | -75.53%10.7M | -75.62%10.15M | -46.64%22.93M | -54.78%28.03M | 14.77%43.72M | 14.77%43.72M | 99.13%41.62M |
| Free cash flow | 60.02%-10.61M | 66.63%-14.39M | 61.21%-102.69M | 73.12%-13.44M | 70.36%-19.58M | 63.84%-26.54M | 42.71%-43.13M | -47.11%-264.75M | 18.39%-49.99M | -29.21%-66.08M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
